Why Real-World Data Matters to Patients

Healthcare systems worldwide are increasingly recognising the value of healthcare data. From improving care pathways to identifying potential cost savings through data analytics, one of the most important measures of its value is its impact on patient outcomes.

Reliable data can support safer, more effective and more personalised care. As technology makes new datasets and more sophisticated analytical tools available, the ability to interpret and apply this information will be essential to improving health outcomes and developing more sustainable healthcare models.

Yet while the value of longitudinal, real-world health data is widely recognised by healthcare organisations, policymakers, researchers, academics and pharmaceutical companies, more could be done to help patients understand how their data is used. Greater awareness can help individuals understand how their participation may contribute to better care for themselves and other patients, according to Samir Dhalla, Head of THIN, and Richard Ballerand, Co-Chair of THIN’s Patient Advisory Committee.

How Does Patient Data Benefit Public Health?

Public awareness of the importance of health data increased during the COVID-19 pandemic. In the UK, NHS data was used to identify approximately 2.2 million people who were advised to shield. Health records were also analysed to better understand differences in patient outcomes, including the risks associated with conditions such as obesity and Type 2 diabetes.

These developments highlighted the value of real-world health records in understanding disease patterns and informing public health responses.

National and international collaboration also accelerated during the pandemic. The UK government established the NHS COVID-19 Data Store to support the use of data in managing the crisis. The European Health Data and Evidence Network (EHDEN) participated in the OHDSI COVID-19 Virtual Study-a-thon, which brought together 330 researchers from different disciplines and 30 countries. EHDEN also launched a COVID-19 Rapid Collaboration Call to help address fragmented, siloed and poorly interoperable real-world health data.

These initiatives demonstrated how better access to and collaboration around health data can help researchers characterise patient populations, inform care decisions and assess treatment safety.

Population health data is particularly important for identifying and managing large-scale health threats. Analysis of 16.2 million anonymised longitudinal patient records reportedly identified an increase in the proportion of lower respiratory tract infections diagnosed in late 2019 compared with previous flu seasons. This raised questions about whether COVID-19 may have been circulating in the UK earlier than initially recognised.

Electronic health records can support the monitoring of population health trends, helping public health bodies identify potential signals, investigate emerging risks and respond more effectively. However, the reliability of these insights depends on data quality, coverage, analytical methods and appropriate interpretation.

Why Is Trust Essential When Using Patient Data?

Although awareness of the value of patient data has grown, public trust remains essential to its responsible use.

Research has found that people can be supportive of anonymised medical records being used to improve healthcare and advance medical research, particularly when the benefits to society are clear. However, concerns remain about how health data is accessed, who can use it and whether commercial organisations might exploit it.

Healthcare organisations therefore need to explain not only how patient data is collected and protected, but also how its use can benefit individuals and the wider population. Transparency, appropriate safeguards and clear governance are important for maintaining public confidence.

Demonstrating practical benefits can also help reinforce the value of responsible data use. These benefits include earlier diagnosis, more informed treatment decisions, improved understanding of disease patterns and better allocation of healthcare resources.

How Can Healthcare Data Support Earlier Diagnosis?

One of the most visible benefits of effective patient data analysis is the potential to improve diagnostic decisions.

By comparing anonymised patient-level information with clinical guidance, such as recommendations from the National Institute for Health and Care Excellence (NICE), healthcare professionals can gain a clearer understanding of how treatments and care pathways perform across different patient groups.

Analysing patterns across factors such as age, weight, ethnicity, existing conditions and lifestyle can help clinicians understand how patients with different characteristics may respond to treatment. This information can support more informed decisions and help identify opportunities for earlier intervention.

Pancreatic cancer illustrates why earlier diagnosis matters. The disease can progress rapidly, and its symptoms — including unexplained weight loss, jaundice, abdominal pain and indigestion — may resemble those of other conditions.

Making relevant clinical information more accessible within healthcare systems could help general practitioners recognise warning signs, consider appropriate investigations and refer patients to specialists sooner when indicated. Earlier assessment may improve the opportunity for timely treatment, although outcomes depend on the disease, its stage and individual circumstances.

More broadly, integrating relevant patient data into clinical workflows can help healthcare professionals make better-informed decisions while reducing avoidable delays and supporting more appropriate use of healthcare resources.

How Does Predictive Modelling Support Personalised Medicine?

Real-world health data can also help researchers and clinicians understand how patients respond to different treatments, medicines and surgical procedures.

When combined with predictive modelling, this information can reveal patterns associated with treatment outcomes and help healthcare providers move towards more personalised approaches to care. Pharmaceutical companies and healthcare services can use these insights to investigate which treatments may be most suitable for particular patient groups.

The goal is to move closer to the principle of providing the right treatment to the right patient at the right time, while recognising that predictive models inform clinical decisions rather than replace professional judgement.

For example, analysis of cardiac surgery data can help researchers evaluate risks associated with particular procedures and recovery outcomes. Factors such as age, ethnicity, existing conditions and other patient characteristics may help explain differences in risk and recovery.

Predictive modelling can also help patients better understand their health risks and the potential benefits of changes to their lifestyle or behaviour. This approach aligns with predictive, preventive and personalised medicine (PPPM), which combines individual and population health information to identify risks, support prevention and potentially detect health problems earlier.

Why Is Longitudinal Patient Data Important for Preventive Care?

Preventive healthcare depends on identifying potential problems before they become more serious. This requires reliable health information collected over time, including measurements such as weight, cholesterol and blood pressure.

Looking at how these indicators change over months or years can help clinicians identify concerning trends. Predictive models may then help estimate possible future outcomes and support discussions about appropriate preventative measures.

Longitudinal patient data can therefore contribute to more personalised advice and help healthcare professionals identify when additional monitoring, lifestyle changes or clinical intervention may be appropriate.

Predictive and preventive approaches may also help reduce avoidable pressure on hospitals by supporting appropriate care in primary healthcare settings. At a population level, aggregated data can help healthcare planners identify emerging needs, anticipate demand and allocate resources to the services most likely to require them.

These benefits depend on the quality of the underlying data, the suitability of the analytical methods and the ability of healthcare services to act on the findings.

Why Does Healthcare Analytics Require High-Quality Data?

The effectiveness of healthcare analytics depends on access to sufficiently large volumes of reliable, representative and relevant patient data.

Researchers need robust datasets to identify meaningful patterns, evaluate treatments and develop medical technologies. Where access to real-world patient data is limited, synthetic datasets — artificially generated information designed to reflect selected characteristics of real data — can help support software development, testing and some research activities.

However, synthetic data may not capture every complexity, variation or relationship found in real patient populations. Its usefulness depends on how accurately it represents the characteristics relevant to a particular analysis. It should therefore be assessed carefully before being used to support clinical or population health conclusions.

Real-world patient data can provide valuable evidence about how diseases develop, how treatments perform in practice and how healthcare needs change over time. To realise this potential, organisations must balance data accessibility with privacy protection, appropriate governance and public trust.

Conclusion: How Can Patient Data Improve Healthcare Outcomes?

Patient data can play a vital role in improving individual care and population health. When collected, managed and analysed responsibly, it can help healthcare professionals identify trends, inform patient pathways, evaluate clinical effectiveness and make better-informed decisions.

Primary care data, in particular, can provide insights into patterns of disease, local healthcare needs and opportunities to improve diagnosis and prevention. General practitioners and other healthcare professionals can contribute to medical research that advances understanding, informs policy and supports the development of more effective care.

Patients also have a role to play. Understanding how their health information may be used — and the safeguards that govern its use — can help them make informed decisions about participation in research and other appropriate data initiatives.

Ultimately, the value of healthcare data is measured not simply by the volume of information collected, but by whether it leads to meaningful improvements in diagnosis, treatment, prevention and patient outcomes.